Vitamin D and inflammation

Dermato-Endocrinology

Volumn 6, Issue 1, 2014, Pages

  Cannell, John J ^a   Grant, William B ^b   Holick, Michael F ^c  

^a Vitamin D Council   (United States)

^b Sunlight   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Cardiovascular disease; Cytokines; Inflammation; Randomized controlled trials; Tumor necrosis factoralpha; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; CALCIFEDIOL; COLECALCIFEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOTAXIN; ERGOCALCIFEROL; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

HUMAN; INFLAMMATION; LUPUS VULGARIS; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; TUBERCULOSIS;

EID: 84929347756     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/19381980.2014.983401     Document Type: Review

References (93)

1. Han QQ, Yu J. Inflammation: a mechanism of depression? Neurosci Bull 2014; 30:515-23; PMID:24838302; http://dx.doi.org/10.1007/s12264-013-1439-3
2. Christodoulidis G, Vittorio TJ, Fudim M, Lerakis S, Kosmas CE. Inflammation in coronary artery disease. Cardiol Rev 2014; 22:279-88; PMID:24441047; http://dx.doi.org/10.1097/CRD.0000000000000006
3. Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol 2014; 26:54-74; PMID:24552665; http://dx.doi.org/10.1016/j.smim.2014.01.001
4. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res Ther 2005; 7Suppl; 2:S4-14; http://dx. doi.org/10.1186/ar1703
5. Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clinimmunol 2010; 125:S53-72; http://dx.doi.org/10.1016/j.jaci.2009.07.008
6. Tayal V, Kalra BS. Cytokines and anti-cytokines as therapeutics-an update. Eur J Pharmacol 2008; 579:1-12; PMID:18021769; http://dx.doi.org/10.1016/j. ejphar.2007.10.049
7. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014; 2:76-89; PMID:24622671; http:// dx.doi.org/10.1016/S2213-8587(13)70165-7
8. Henriksen VT, Rogers VE, Rasmussen GL, Trawick RH, Momberger NG, Aguirre D, Barker T. Proinflammatory cytokines mediate the decrease in serum 25(OH)D concentrations after total knee arthroplasty? Med Hypotheses 2014; 82:134-7; PMID:24332533; http://dx.doi.org/10.1016/j.mehy.2013.11.020
9. Mangge H, Weghuber D, Prassl R, Haara A, Schnedl W, Postolache TT, Fuchs D. The role of vitamin D in atherosclerosis inflammation revisited: more a bystander than a player? Curr Vasc Pharmacol 2013. [Epub ahead of print]; PMID:24329737
10. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine 2010; 77:552-7; PMID:21067953; http://dx.doi.org/10.1016/j.jbspin. 2010.09.018
11. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4:404-12; PMID:18594491; http:// dx.doi.org/10.1038/ncprheum0855
12. Marcotorchino J, Gouranton E, Romier B, Tourniaire F, Astier J, Malezet C, Amiot MJ, Landrier JF. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res 2012; 56:1771-82; PMID:23065818; http://dx.doi.org/ 10.1002/mnfr.201200383
13. Barker T, Martins TB, Kjeldsberg CR, Trawick RH, Hill HR. Circulating interferon-γ correlates with 1,25 (OH)D and the 1,25(OH)D-to-25(OH)D ratio. Cytokine 2012; 60:23-6; PMID:22704696; http://dx.doi. org/10.1016/j.cyto.2012.05.015
14. Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, Chugh S, Deshpande S, Ford C, Gama R. Vitamin D: a negative acute phase reactant. J Clin Pathol 2013; 66:620-2; PMID:23454726; http://dx.doi.org/10.1136/jclinpath-2012-201301
15. Reid D, Toole BJ, Knox S, Talwar D, Harten J, O'Reilly DS, Blackwell S, Kinsella J, McMillan DC, Wallace AM. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011; 93:1006-11; PMID:21411617; http://dx.doi.org/10.3945/ajcn. 110.008490
16. Guo J, Ma Z, Ma Q, Wu Z, Fan P, Zhou X, Chen L, Zhou S, Goltzman D, Miao D, Wu E. 1, 25(OH)2D3 inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Curr Med Chem 2013; 20:4131-41; PMID:23992309; http://dx.doi.org/10.2174/ 09298673113209990248
17. Korf H, Wenes M, Stijlemans B, Takiishi T, Robert S, Miani M, Eizirik DL, Gysemans C, Mathieu C. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology 2012; 217:1292-300; PMID:22944250; http://dx.doi.org/ 10.1016/j.imbio.2012.07.018
18. Feng X, Lv C, Wang F, Gan K, Zhang M, Tan W. Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β-induced RANKL, OPG, TNF α, and IL-6 expression in human rheumatoid synoviocyte MH7A. Clin Dev Immunol 2013; 2013:160123; PMID:24348674; http://dx.doi.org/10.1155/2013/ 160123
19. Erbaş O, Solmaz V, Aksoy D, Yavaşoğlu A, Sağcan M, Taşkıran D. Cholecalciferol (vitamin D 3) improves cognitive dysfunction and reduces inflammation in a rat fatty liver model of metabolic syndrome. Life Sci 2014; 103:68-72; PMID:24727236; http://dx.doi.org/ 10.1016/j.lfs.2014.03.035
20. Adzemovic MZ, Zeitelhofer M, Hochmeister S, Gustafsson SA, Jagodic M. Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage. Exp Neurol 2013; 249:39-48; PMID:23954214; http://dx.doi.org/10.1016/j. expneurol.2013.08.002
21. Yilmaz SS, Hizli D, Yilmaz E, Eryilmaz OG, Hizli F, Haltaş H. Effect of vitamin D on postoperative adhesion formation in a rat uterine horn adhesion model. J Reprod Med 2013; 58:511-6; PMID:24568046
22. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine 2010; 77:552-7; PMID:21067953; http://dx.doi.org/10.1016/j.jbspin.2010.09.018
23. Aranow C. Vitamin D and the immune system. J Investig Med 2011; 59:881-6; PMID:21527855
24. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 2012; 109:226-230; PMID:21996139; http://dx.doi.org/10.1016/j.amjcard.2011.08.032
25. Bellia A, Garcovich C, D'Adamo M, Lombardo M, Tesauro M, Donadel G, Gentileschi P, Lauro D, Federici M, Lauro R, et al. Serum 25-hydroxyvitamin D concentration are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 2013; 8:33-40; PMID:21437585; http://dx.doi. org/10.1007/s11739-011-0559-x
26. Hart PH, Gorman S. Exposure to UV wavelengths in sunlight suppresses immunity. To what extent is UVinduced vitamin D3 the mediator responsible? Clin Biochem Rev 2013; 34:3-13; PMID:23592888
27. Wang Y, Marling SJ, McKnight SM, Danielson AL, Severson KS, Deluca HF. Suppression of experimental autoimmune encephalomyelitis by 300-315nm ultraviolet light. Arch Biochem Biophys 2013; 536:81-6; PMID:23747577; http://dx.doi.org/10.1016/j. abb.2013.05.010
28. Barker T, Henriksen VT, Martins TB, Hill HR, Kjeldsberg CR, Schneider ED, Dixon BM, Weaver LK. Higher serum 25-hydroxyvitamin D concentrations associate with a faster recovery of skeletal muscle strength after muscular injury. Nutrients 2013; 5:1253-75; PMID:23595134; http://dx.doi.org/10.3390/ nu5041253
29. Barker T, Schneider ED, Dixon BM, Henriksen VT, Weaver LK. Supplemental vitamin D enhances the recovery in peak isometric force shortly after intense exercise. Nutr Metab (Lond) 2013; 10:69; PMID:24313936; http://dx.doi.org/10.1186/1743-7075-10-69
30. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81; PMID:17634462; http://dx.doi. org/10.1056/NEJMra070553
31. Hewison M. Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl 2012; 243:92-102; PMID:22536769
32. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81; PMID:17634462; http://dx.doi. org/10.1056/NEJMra070553
33. Kaseda R, Hosojima M, Sato H, Saito A. Role of megalin and cubilin in the metabolism of vitamin D(3). Ther Apher Dial 2011; 15(Suppl 1):14-7PMID:21595846; http://dx.doi.org/10.1111/j.1744-9987.2011.00920.x
34. Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick MF. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation. J Clin Endocrinol Metab 2013; 98:973-9; PMID:23386645; http://dx.doi.org/10.1210/jc.2012-2114
35. Carlberg C. Genome-wide (over)view on the actions of vitamin D. Front Physiol 2014; 5:167; PMID:24808867
36. Hossein-Nezhad A, Spira A, Holick MF. Influence of vitamin d status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One 2013; 8: e58725; PMID:23527013; http://dx.doi.org/10.1371/ journal.pone.0058725
37. Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 1971; 33:992-5; PMID:4332615; http:// dx.doi.org/10.1210/jcem-33-6-992
38. Luxwolda MF, Kuipers RS, Kema IP, Dijck-Brouwer DA, Muskiet FA. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 2012; 108:1557-61; PMID:22264449; http://dx.doi.org/ 10.1017/S0007114511007161
39. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J ClinNutr 2003; 77:204-10; PMID:12499343
40. Nieman DC, Gillitt ND, Shanely RA, Dew D, Meaney MP, Luo B. Vitamin D2 supplementation amplifies eccentric exercise-induced muscle damage in NASCAR pit crew athletes. Nutrients 2013; 6:63-75; PMID:24362707; http://dx.doi.org/10.3390/nu6010063
41. Zanetti M, Harris SS, Dawson-Hughes B. Ability of vitamin D to reduce inflammation in adults without acute illness. Nutr Rev 2014; 72:95-8; PMID:24330160; http://dx.doi.org/10.1111/nure. 12095
42. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 2012; 7:e36617; PMID:22586483; http://dx.doi.org/ 10.1371/journal.pone.0036617
43. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30:980-6; PMID:17277040 http://dx.doi.org/10.2337/dc06-1994
44. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br J Nutr 2010; 103:549-55; PMID:19781131; http://dx.doi.org/10.1017/S000711 4509992017
45. Bjorkman MP, Sorva AJ, Tilvis RS.C-reactive protein and fibrinogen of bedridden older patients in a sixmonth vitamin D supplementation trial. J Nutr Health Aging 2009; 13:435-9; PMID:19390750; http://dx. doi.org/10.1007/s12603-009-0080-3
46. Barnes MS, Horigan G, Cashman KD, Hill TR, Forsythe LK, Lucey AJ, McSorley EM, Kiely M, Bonham MP, Magee PJ, et al. Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. J Nutr 2011; 141:476-81; PMID:21270359; http://dx.doi.org/10.3945/jn.110.131516
47. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012; 97:3557-68; PMID:22865902; http://dx.doi.org/10.1210/jc.2012-2126
48. Chandler PD, Scott JB, Drake BF, Ng K, Manson JE, Rifai N, Chan AT, Bennett GG, Hollis BW, Giovannucci EL, et al. Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial. Cancer Prev Res (Phila) 2014; 7:218-25; PMID:24327720; http://dx.doi.org/10.1158/1940-6207.CAPR-13-0338-T
49. Bischoff-Ferrari HA, Dawson-Hughes B, Stöcklin E, Stöcklin E, Sidelnikov E, Willett WC, Edel JO, Stähelin HB, Wolfram S, Jetter A, et al. Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D concentration, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res 2012; 27:160-9; PMID:22028071; http://dx.doi.org/10.1002/jbmr.551
50. Asemi Z, Samimi M, Tabassi Z, Shakeri H, Esmaillzadeh A. Vitamin D supplementation affects serum highsensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr 2013; 143:1432-8; PMID:23884390; http://dx. doi.org/10.3945/jn.113.177550
51. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Gøransson LG, Omdal R. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 2010; 50:175-80; PMID:20122848; http://dx.doi.org/ 10.1016/j.cyto.2009.12.006
52. Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine 2012; 60:870-4; PMID:22925537; http://dx.doi. org/10.1016/j.cyto.2012.07.032
53. Belenchia AM, Tosh AK, Hillman LS, Peterson CA. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 2013; 97:774-81; PMID:23407306; http://dx.doi.org/10.3945/ajcn.112. 050013
54. Carrillo AE, Flynn MG, Pinkston C, Markofski MM, Jiang Y, Donkin SS, Teegarden D. Vitamin D supplementation during exercise training does not alter inflammatory biomarkers in overweight and obese subjects. Eur J Appl Physiol 2012; 112:3045-52; PMID:22183086; http://dx.doi.org/10.1007/s00421-011-2279-3
55. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89:1321-7; PMID:19321573; http://dx.doi.org/10.3945/ajcn.2008. 27004
56. Mason C, Xiao L, Imayama I, Duggan C, Wang CY, Korde L, McTiernan A. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 2014; 99:1015-25; PMID:24622804; http://dx.doi.org/10.3945/ajcn.113. 073734
57. Wamberg L, Kampmann U, Stødkilde-Jørgensen H, Rejnmark L, Pedersen S, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D concentration-results from a randomized trial. Eur J Intern Med 2013; 24:644-9; PMID:23566943; http://dx.doi.org/10.1016/j.ejim. 2013.03.005
58. Hopkins MH, Owen J, Ahearn T, Fedirko V, Flanders WD, Jones DP, Bostick RM. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res (Phila) 2011; 4:1645-54; PMID:21724580; http://dx.doi.org/ 10.1158/1940-6207.CAPR-11-0105
59. Rahimi-Ardabili H, PourghassemGargari B, Farzadi L. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. J Endocrinol Invest 2013; 36:28-32; PMID:22453059
60. Sinha-Hikim I, Duran P, Shen R, Lee M, Friedman TC, Davidson MB. Effect of long term vitamin D supplementation on biomarkers of inflammation in Latino and African-American subjects with pre-diabetes and hypovitaminosis D. Horm Metab Res. 2014. [Epub ahead of print]; PMID:25011019
61. Yiu YF, Yiu KH, Siu CW, Chan YH, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Lau CP, et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013; 227:140-6; PMID:23298824; http://dx.doi.org/10.1016/j.atherosclerosis.2012.12. 013
62. Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 2013; 32:970-5; PMID:23561637; http://dx.doi.org/ 10.1016/j.clnu.2013.01.020
63. Grimnes G, Figenschau Y, Almås B, Jorde R. Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 2011; 60:2748-57; PMID:21911741; http://dx.doi.org/ 10.2337/db11-0650
64. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Kalayi A, Shariatzadeh N, Khalaji N, Gharavi A. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev 2012; 28:424-30; PMID:22344966; http://dx.doi.org/10.1002/dmrr. 2290
65. Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L, Wamberg L, Orskov L. Effects of 12weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency-a double-blind, randomized, placebo-controlled trial. Metabolism 2014; 63:1115-24; PMID:25044176; http://dx.doi.org/10.1016/j. metabol.2014.06.008
66. Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. J Ren Nutr 2012; 22:284-91; PMID:21908203; http://dx.doi.org/ 10.1053/j.jrn.2011.07.001
67. Alvarez JA, Zughaier SM, Law J, Hao L, Wasse H, Ziegler TR, Tangpricha V. Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease. Eur J Clin Nutr 2013; 67:264-9; PMID:23361158; http://dx.doi. org/10.1038/ejcn.2012.217
68. Sokol SI, Srinivas V, Crandall JP, Kim M, Tellides G, Lebastchi AH, Yu Y, Gupta AK, Alderman MH. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med 2012; 17:394-404; PMID:23184900; http://dx.doi.org/10.1177/1358863X12466709
69. Stricker H, TosiBianda F, Guidicelli-Nicolosi S, Limoni C, Colucci G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 2012; 44:307-12; PMID:22831874 http://dx.doi.org/ 10.1016/j.ejvs.2012.06.023
70. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail 2010; 3:195-201; PMID:20103775 http://dx.doi.org/10.1161/ CIRCHEARTFAILURE.109.907899
71. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83:754-9; PMID:16600924
72. Longenecker CT, Hileman CO, Carman TL, Ross AC, Seydafkan S, Brown TT, Labbato DE, Storer N, Tangpricha V, McComsey GA. Vitamin D supplementation and endothelial function in vitamin D deficient HIVinfected patients: a randomized placebo-controlled trial. Antivir Ther 2012; 17:613-21; PMID:22293363; http://dx.doi.org/10.3851/IMP1983
73. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003; 134:128-32; PMID:12507780; http://dx. doi.org/10.1016/S0165-5728(02)00396-X
74. Pappa HM, Mitchell PD, Jiang H, Kassiff S, Filip-Dhima R, DiFabio D, Quinn N, Lawton RC, Bronzwaer ME, Koenen M, et al. Maintenance of optimal vitamin D status in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing two regimens. J Clin Endocrinol Metab 2014; 99:3408-17; PMID: 24926949; http://dx.doi. org/10.1210/jc.2013-4218
75. Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr 2012; 66:1072-4; PMID:22805498; http://dx. doi.org/10.1038/ejcn.2012.82
76. Shedeed SA. Vitamin D supplementation in infants with chronic congestive heart failure. Pediatr Cardiol 2012; 33:713-9; PMID:22349668; http://dx.doi.org/ 10.1007/s00246-012-0199-6
77. Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebocontrolled trial. J Rheumatol 2013; 40:265-72; PMID:23204220; http://dx.doi.org/10.3899/jrheum. 111594
78. Hansen KE, Bartels CM, Gangnon RE, Jones AN, Gogineni J. An evaluation of high-dose vitamin D for rheumatoid arthritis. J Clin Rheumatol 2014; 20:112-4; PMID:24561419
79. Arnson Y, Itzhaky D, Mosseri M, Barak V, Tzur B, Agmon-Levin N, Amital H. Vitamin D inflammatory cytokines and coronary events: a comprehensive review. Clin Rev Allergy Immunol 2013; 45:236-47; PMID:23314982; http://dx.doi.org/10.1007/s12016-013-8356-0
80. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A 2012; 109:15449-54; PMID:22949664; http://dx.doi.org/ 10.1073/pnas.1200072109
81. http://www.hutchon.net/confidrr.htm (accessed August 16, 2014)
82. Grant WB. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 2010; 101:130-6; PMID:20570169; http://dx.doi.org/ 10.1016/j.jphotobiol.2010.04.008
83. Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 5:819-29; PMID:23149428; http://dx.doi.org/ 10.1161/CIRCOUTCOMES.112.967604
84. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014; 72:48-54; PMID:24330136; http://dx.doi.org/ 10.1111/nure.12090
85. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012; 33:159-71; PMID:21986389; http://dx.doi.org/ 10.1016/j.cct.2011.09.009
86. CimminoMA, ParodiM,Montecucco C, Caporali R. The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. BMC Musculoskelet Disord 2011; 12:94; PMID:21569559; http://dx.doi.org/10.1186/1471-2474-12-94
87. Stamp TC, Haddad JG, Twigg CA. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet 1977; 1:1341-3; PMID:69059; http:// dx.doi.org/10.1016/S0140-6736(77)92553-3
88. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69:842-56; PMID:10232622
89. Soilu-Hanninen M, Aivo J, Lindstrom BM, Elovaara I, Sumelahti ML, Färkkilä M, Tienari P, Atula S, Sarasoja T, Herrala L, et al. A randomised, double blind, placebo controlled trial with vitamin d3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2012; 83:565-71; PMID:22362918; http://dx.doi.org/10.1136/jnnp-2011-301876
90. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'. BMC Infect Dis 2013; 13: 22; PMID:23331510; http://dx.doi.org/10.1186/1471-2334-13-22
91. Dehghan A, Rahimpour S, Soleymani-Salehabadi H, Owlia MB. Role of vitamin D in flare ups of rheumatoid arthritis. Z Rheumatol 2014; 73:461-4; PMID:24352479; http://dx.doi.org/10.1007/s00393-013-1297-4
92. Cutillas-Marco E, Marquina-Vila A, Grant W, Vilata-Corell J, Morales-Suárez-Varela M. Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity. Lupus 2014 Feb 6. [Epub ahead of print]; PMID:24503020
93. Kimball SM, Ursell MR, O'Connor P, Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 2007; 86:645-51; PMID:17823429